BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20413956)

  • 1. UK Renal Registry 12th Annual Report (December 2009): chapter 4: UK ESRD prevalent rates in 2008: national and centre-specific analyses.
    Byrne C; Steenkamp R; Castledine C; Ansell D; Feehally J
    Nephron Clin Pract; 2010; 115 Suppl 1():c41-67. PubMed ID: 20413956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses.
    Steenkamp R; Castledine C; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c27-52. PubMed ID: 21894040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK Renal Registry 15th annual report: Chapter 2 UK RRT prevalence in 2011: national and centre-specific analyses.
    Shaw C; Pruthi R; Pitcher D; Fogarty D
    Nephron Clin Pract; 2013; 123 Suppl 1():29-54. PubMed ID: 23774485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK Renal Registry 16th annual report: chapter 2 UK RRT prevalence in 2012: national and centre-specific analyses.
    Shaw C; Pitcher D; Pruthi R; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):29-53. PubMed ID: 24662166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses.
    Farrington K; Hodsman A; Casula A; Ansell D; Feehally J
    Nephron Clin Pract; 2009; 111 Suppl 1():c43-68. PubMed ID: 19542705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses.
    Castledine C; Casula A; Fogarty D
    Nephron Clin Pract; 2012; 120 Suppl 1():c29-54. PubMed ID: 22964573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK Renal Registry 12th Annual Report (December 2009): chapter 3: UK ESRD incident rates in 2008: national and centre-specific analyses.
    Byrne C; Ford D; Gilg J; Ansell D; Feehally J
    Nephron Clin Pract; 2010; 115 Suppl 1():c9-39. PubMed ID: 20413958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2013: National and Centre-specific Analyses.
    Rao A; Casula A; Castledine C
    Nephron; 2015; 129 Suppl 1():31-56. PubMed ID: 25695806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses.
    MacNeill SJ; Casula A; Shaw C; Castledine C
    Nephron; 2016; 132 Suppl 1():41-68. PubMed ID: 27116553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK Renal Registry 13th Annual Report (December 2010): Chapter 1: UK RRT incidence in 2009: national and centre-specific analyses.
    Gilg J; Castledine C; Fogarty D; Feest T
    Nephron Clin Pract; 2011; 119 Suppl 2():c1-25. PubMed ID: 21894028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UK Renal Registry 15th annual report: Chapter 1 UK RRT incidence in 2011: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 123 Suppl 1():1-28. PubMed ID: 23774484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All patients receiving renal replacement therapy in the United Kingdom in 2005 (chapter 4).
    Farrington K; Rao R; Stenkamp R; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii30-50. PubMed ID: 17724051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK Renal Registry 12th Annual Report (December 2009): chapter 7: survival and causes of death of UK adult patients on renal replacement therapy in 2008: national and centre-specific analyses.
    Ansell D; Roderick P; Steenkamp R; Tomson CR
    Nephron Clin Pract; 2010; 115 Suppl 1():c117-44. PubMed ID: 20413945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: national and centre-specific analyses.
    Farrington K; Udayaraj U; Gilg J; Feehally J
    Nephron Clin Pract; 2009; 111 Suppl 1():c13-41. PubMed ID: 19542695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK Renal Registry 13th Annual Report (December 2010): Chapter 6: survival and causes of death of UK adult patients on renal replacement therapy in 2009: national and centre-specific analyses.
    Castledine C; Steenkamp R; Feest T; Tomson CR
    Nephron Clin Pract; 2011; 119 Suppl 2():c107-34. PubMed ID: 21894029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Renal Registry 17th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2013: National and Centre-specific Analyses.
    Gilg J; Pruthi R; Fogarty D
    Nephron; 2015; 129 Suppl 1():1-29. PubMed ID: 25695805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK Renal Registry 12th Annual Report (December 2009): chapter 11: blood pressure profile of prevalent patients receiving dialysis in the UK in 2008: national and centre-specific analyses.
    Harper J; Nicholas J; Webbc L; Casula A; Williams AJ
    Nephron Clin Pract; 2010; 115 Suppl 1():c239-60. PubMed ID: 20413949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses.
    Gilg J; Castledine C; Fogarty D
    Nephron Clin Pract; 2012; 120 Suppl 1():c1-27. PubMed ID: 22964563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New adult patients starting renal replacement therapy in the UK in 2005 (chapter 3).
    Farrington K; Rao R; Gilg J; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii11-29. PubMed ID: 17724040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.